"Although the effectiveness of ADHD medications has been demonstrated ... concerns remain regarding their potential cardiovascular safety," one research explained. 

While the therapy has been successfully tested on animals in the past, this study represents the first time it has been used on humans.

The COVID-19 pandemic undid years and years of progress in terms of preventing CVD-related deaths. What can be done to help reverse this trend once and for all? 

“Going forward, patients and medical teams have a choice of two pathways for chest pain relief: chest pain medication or PCI," one cardiologist said. 

One key difference between this new risk calculator and previous methods is that it does not consider a patient's race or ethnicity. It does, however, consider such factors as where the patient lives, their education and their income level. 

The new-look algorithm, trained and validated with data from more than 25,000 patients, scans a patient's electronic health record and identifies signs of trouble. 

CLAiR offers physicians another way to evaluate a patient’s cardiovascular health: non-invasive retinal images captured during routine eye exams.

Intravascular lithotripsy therapy to break up calcified coronary lesions will now be reimbursed at a higher rate under new in-hospital codes the went into effect Oct. 1.